Union Bancaire Privee’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Sell
16,462
-559
-3% -$37.2K 0.02% 245
2026
Q1
$1.83M Sell
17,021
-4,245
-20% -$296K 0.03% 243
2025
Q4
$2.24M Buy
21,266
+15,802
+289% +$1.02M 0.03% 215
2025
Q3
$346K Buy
5,464
+3,084
+130% +$244K ﹤0.01% 348
2025
Q2
$158K Sell
2,380
-3,625
-60% -$284K ﹤0.01% 382
2025
Q1
$345K Buy
6,005
+3,005
+100% +$245K 0.01% 338
2024
Q4
$225K Buy
+3,000
New +$222K ﹤0.01% 400

Other funds holding DXCM

Union Bancaire Privee's DXCM Position: Q2 2026 in Review

Union Bancaire Privee reduced its DexCom (DXCM) stake by 3.3% in Q2 2026, selling an estimated $37.2K and leaving 16,462 shares worth $2.03M. The position accounts for 0.02% of the portfolio, ranked #245.

Union Bancaire Privee first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.24M in Q4 2025. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Union Bancaire Privee held 16,462 shares of DexCom worth $2.03M as of Q2 2026.
  • Union Bancaire Privee sold 559 DexCom shares in Q2 2026, an estimated $37.2K.
  • DexCom made up 0.02% of Union Bancaire Privee's portfolio in Q2 2026, its #245 holding.
  • Union Bancaire Privee first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's DexCom position peaked at $2.24M in Q4 2025.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.